|Bid||81.03 x 1000|
|Ask||81.13 x 1400|
|Day's range||77.64 - 84.11|
|52-week range||62.55 - 217.25|
|Beta (5Y monthly)||1.62|
|PE ratio (TTM)||N/A|
|Earnings date||21 Feb 2024 - 26 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||134.16|
CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.
Carnival (NYSE: CCL) (NYSE: CUK) shares have climbed 95% this year, but they're still trading way below their pre-pandemic levels. Things weren't easy for Carnival at the start of the health crisis since it was forced to halt sailings -- and debt ballooned so the company could stay afloat. Carnival's latest earnings reports offer us reason to be optimistic.